These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31706900)

  • 1. A novel isothiocyanate derivative inhibits HIV-1 gene expression and replication by modulating the nuclear matrix associated protein SMAR1.
    Trivedi J; Alam A; Joshi S; Kumar TP; Chippala V; Mainkar PS; Chandrasekhar S; Chattopadhyay S; Mitra D
    Antiviral Res; 2020 Jan; 173():104648. PubMed ID: 31706900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, β-catenin, and SMAR1 to repress HIV transcription.
    Henderson LJ; Narasipura SD; Adarichev V; Kashanchi F; Al-Harthi L
    J Virol; 2012 Sep; 86(17):9495-503. PubMed ID: 22674979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling.
    Sreenath K; Pavithra L; Singh S; Sinha S; Dash PK; Siddappa NB; Ranga U; Mitra D; Chattopadhyay S
    Virology; 2010 Apr; 400(1):76-85. PubMed ID: 20153010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaffold attachment factor B suppresses HIV-1 infection of CD4
    Ma L; Sun L; Jin X; Xiong SD; Wang JH
    J Biol Chem; 2018 Aug; 293(31):12177-12185. PubMed ID: 29887524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-κB-dependent HIV-1 replication by the marine natural product bengamide A.
    Tietjen I; Williams DE; Read S; Kuang XT; Mwimanzi P; Wilhelm E; Markle T; Kinloch NN; Naphen CN; Tenney K; Mesplède T; Wainberg MA; Crews P; Bell B; Andersen RJ; Brumme ZL; Brockman MA
    Antiviral Res; 2018 Apr; 152():94-103. PubMed ID: 29476895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.
    Chang TL; Mosoian A; Pine R; Klotman ME; Moore JP
    J Virol; 2002 Jan; 76(2):569-81. PubMed ID: 11752148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.
    Alam A; Taye N; Patel S; Thube M; Mullick J; Shah VK; Pant R; Roychowdhury T; Banerjee N; Chatterjee S; Bhattacharya R; Roy R; Mukhopadhyay A; Mogare D; Chattopadhyay S
    Neoplasia; 2019 Oct; 21(10):945-962. PubMed ID: 31422285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
    Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
    Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
    Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
    Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
    Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
    EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
    Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
    J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear matrix protein SMAR1 represses c-Fos-mediated HPV18 E6 transcription through alteration of chromatin histone deacetylation.
    Chakraborty S; Das K; Saha S; Mazumdar M; Manna A; Chakraborty S; Mukherjee S; Khan P; Adhikary A; Mohanty S; Chattopadhyay S; Biswas SC; Sa G; Das T
    J Biol Chem; 2014 Oct; 289(42):29074-85. PubMed ID: 25157104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUN2 Modulates HIV-1 Infection and Latency through Association with Lamin A/C To Maintain the Repressive Chromatin.
    Sun WW; Jiao S; Sun L; Zhou Z; Jin X; Wang JH
    mBio; 2018 May; 9(3):. PubMed ID: 29717016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription.
    Hayashi T; Jean M; Huang H; Simpson S; Santoso NG; Zhu J
    Antiviral Res; 2017 Oct; 146():76-85. PubMed ID: 28842263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshifting.
    Roesmann F; Sertznig H; Klaassen K; Wilhelm A; Heininger D; Heß S; Elsner C; Marschalek R; Santiago ML; Esser S; Sutter K; Dittmer U; Widera M
    J Virol; 2024 Jul; 98(7):e0053424. PubMed ID: 38899932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibition of Tat-dependent HIV-1 replication in chronically infected cells by a novel naphthalene derivative JTK-101.
    Wang X; Yamataka K; Okamoto M; Ikeda S; Baba M
    Antivir Chem Chemother; 2007; 18(4):201-11. PubMed ID: 17907378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 2-isoxazol-3-yl-acetamide analogues as heat shock protein 90 (HSP90) inhibitors with significant anti-HIV activity.
    Trivedi J; Parveen A; Rozy F; Mitra A; Bal C; Mitra D; Sharon A
    Eur J Med Chem; 2019 Dec; 183():111699. PubMed ID: 31561045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
    Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
    J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.